Literature DB >> 2437450

Variant surface glycoproteins of Trypanosoma congolense bloodstream and metacyclic forms are anchored by a glycolipid tail.

C A Ross, M L Cardoso de Almeida, M J Turner.   

Abstract

The variant surface glycoproteins (VSGs) of both metacyclic and bloodstream forms of Trypanosoma congolense are shown to be anchored to the plasma membrane through a glycolipid similar to that found in Trypanosoma brucei. Release of soluble VSG from both metacyclic and bloodstream forms is associated with the exposure of an antigenic determinant homologous to the cross-reacting determinant of T. brucei VSGs. Release of soluble VSG of T. congolense can be achieved by lysates of both bloodstream and metacyclic forms of T. congolense, by lysates of T. brucei bloodstream forms, but not by lysates of procyclic forms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437450     DOI: 10.1016/0166-6851(87)90045-4

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  4 in total

1.  Trypanosomosis research at the Centre for Tropical Veterinary Medicine (CTVM) 1970 to 1995.

Authors:  R Boid; A G Hunter; T W Jones; C A Ross; D Sutherland; A G Luckins
Journal:  Trop Anim Health Prod       Date:  1996-02       Impact factor: 1.559

2.  Trypanocidal activity of a myristic acid analog in axenic cultures of Trypanosoma evansi.

Authors:  C A Ross; A M Taylor
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

Review 3.  The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes.

Authors:  M J McConville; M A Ferguson
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

4.  The glycosylphosphatidylinositol-PLC in Trypanosoma brucei forms a linear array on the exterior of the flagellar membrane before and after activation.

Authors:  Orla Hanrahan; Helena Webb; Robert O'Byrne; Elaine Brabazon; Achim Treumann; Jack D Sunter; Mark Carrington; H Paul Voorheis
Journal:  PLoS Pathog       Date:  2009-06-05       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.